PHI with Vaginal candidiasis
How does this condition affect your private health insurance?
Scheidenpilz, medically known as vulvovaginal candidiasis, is a common fungal infection of the vagina and vulva, primarily caused by Candida albicans. It results from an overgrowth of naturally occurring yeast, often triggered by antibiotic use, hormonal changes, a weakened immune system, or uncontrolled diabetes. Symptoms typically include intense itching, burning, redness, and irritation of the vulva and vagina, along with a thick, white, cottage cheese-like vaginal discharge. While usually not serious, it can cause significant discomfort and impact quality of life. Diagnosis is often clinical, sometimes confirmed by microscopic examination. Treatment involves antifungal medications, available as creams, suppositories, or oral tablets.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several days to one week with treatment; longer if untreated.
Duration of Illness (Lifetime)
Can be a one-time event or a recurrent, chronic condition for some individuals.
Cost of Treatment (Initial)
Approximately 10-30 USD for over-the-counter antifungals; 20-100 USD for prescription medications and office visit.
Cost of Treatment (Lifetime)
Highly variable; 10-30 USD if a single occurrence; potentially hundreds of USD over a lifetime for recurrent cases requiring multiple treatments and doctor visits.
Mortality Rate
Extremely low, virtually zero for healthy individuals, as it is rarely life-threatening.
Risk of Secondary Damages
Low for severe physical damage; moderate for persistent discomfort, severe skin irritation, and potential psychological impact; risk of secondary bacterial infections if untreated or due to excessive scratching.
Probability of Full Recovery
High, typically over 90% with appropriate treatment.
Underlying Disease Risk
Moderate; increased risk with diabetes, weakened immune system, prolonged antibiotic use, hormonal changes (e.g., pregnancy, high-dose estrogen contraceptives), and certain underlying systemic conditions.